AVXL
ANAVEX LIFE SCIENCES CORP.
NASDAQ · Healthcare · Biotechnology · US
$2.42
+0.41%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 1.07x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.99x
- Price / sales
- —
- Price / cash flow
- -6.65x
Enterprise value
- Enterprise value
- $106.0M
- EV / sales
- —
- EV / EBITDA
- -4.86x
- EV / EBIT
- -3.46x
- Market cap
- $224.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026